Komori
Terumo (4543) · FactAdvanced

Change in Capital Structure Due to Conversion of Convertible Bonds with Stock Acquisition Rights

First written in FY2019-Q2. 13 of 14 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2022-Q3.

14entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019-Q3 – FY2022-Q32018: 120182019: 420192020: 420202021: 420212022: 1
Same theme, other companies

11 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 31 companies compared. The sentences above are computed from all 31.
Full recordFilings, disclosures and news, newest first
  1. FY2022-Q3AdvancedAnnual report

    「Conversions of convertible bonds with stock acquisition rights were carried out during the third quarter of the current consolidated cumulative period. The book value of the converted bonds was ¥459 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    During the cumulative FY2022-Q3 period, ¥459 million of convertible bonds with stock acquisition rights due 2021 were converted, changing the capital structure through reductions in treasury shares and other measures.
  2. FY2022-Q2AdvancedAnnual report

    「Conversions of convertible bonds with stock acquisition rights were carried out during the second quarter of the current consolidated cumulative period. The book value of the converted bonds was ¥369 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    ¥369 million of convertible bonds with stock acquisition rights due 2021 were converted, and changes in the capital structure continued through reductions in treasury shares and other measures.
  3. FY2022-Q1AdvancedAnnual report

    「Conversions of convertible bonds with stock acquisition rights were carried out during the first quarter of the current consolidated cumulative period. The book value of the converted bonds was ¥39 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    In FY2022-Q1, ¥39 million of convertible bonds with stock acquisition rights due 2021 were converted, and changes in the capital structure from the conversions continued.
  4. FY2021AdvancedAnnual report

    「The decrease of 3,729,713 ordinary treasury shares during the current consolidated fiscal year comprised a decrease of 49,700 shares through the exercise of stock options, a decrease of 50,883 shares through disposals as restricted stock compensation, and a decrease of 3,629,130 shares through the conversion of convertible bonds with stock acquisition rights.」

    Conversions of convertible bonds with stock acquisition rights due 2021 continued, and the capital structure changed during the period through the allocation of 3,629,130 treasury shares.
  5. FY2021-Q3AdvancedAnnual report

    「Conversions of convertible bonds with stock acquisition rights were carried out during the third quarter of the current consolidated cumulative period. The book value of the converted bonds was ¥6,337 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    During the cumulative third quarter of the current consolidated fiscal year, ¥6,337 million of convertible bonds with stock acquisition rights due 2021 were converted, changing the capital structure through the allocation of treasury shares and other measures.
  6. FY2021-Q2AdvancedAnnual report

    「Conversions of convertible bonds with stock acquisition rights were carried out during the second quarter of the current consolidated cumulative period. The book value of the converted bonds was ¥6,049 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    Conversions of convertible bonds with stock acquisition rights due 2021 continued during the cumulative FY2021-Q2 period, amounting to ¥6,049 million. Total equity increased by ¥6.1 billion as a result of the conversions.
  7. FY2021-Q1AdvancedAnnual report

    「Conversions of convertible bonds with stock acquisition rights were carried out during the first quarter of the current consolidated cumulative period. The book value of the converted bonds was ¥3,594 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    In FY2021-Q1, ¥3,594 million of convertible bonds with stock acquisition rights due 2021 were converted, and changes in the capital structure continued through reductions in treasury shares and other measures.
  8. FY2020AdvancedAnnual report

    「During the consolidated fiscal year, total equity increased by ¥1.77 billion, mainly because treasury shares were used for the conversion of convertible bonds with stock acquisition rights.」

    Conversions of convertible bonds with stock acquisition rights continued, and the capital structure changed during the period, mainly due to a reduction of 9,274,687 treasury shares. The 2019 maturity bonds have been fully converted, while the balance of the 2021 maturity bonds was ¥7.4 billion at the end of the period.
  9. FY2020-Q3AdvancedAnnual report

    「During the nine-month consolidated period ended 31 December, convertible bonds with stock acquisition rights were converted. The carrying amount of the converted bonds was ¥16,821 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    ¥16,821 million of convertible bonds with stock acquisition rights due 2021 was converted, and the decline in bonds and borrowings and the change in capital structure continued.
  10. FY2020-Q2AdvancedAnnual report

    「During the six-month consolidated period ended 30 September, convertible bonds with stock acquisition rights were converted. The carrying amount of the converted bonds was ¥10,322 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    During the six-month consolidated period ended 30 September, ¥10,322 million of convertible bonds with stock acquisition rights due 2021 was converted, and the change in capital structure continued.
  11. FY2020-Q1AdvancedAnnual report

    「During the three-month consolidated period ended 30 June, convertible bonds with stock acquisition rights were converted. The carrying amount of the converted bonds was ¥435 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    During the first quarter, ¥435 million of convertible bonds with stock acquisition rights due 2021 was converted, and the change in capital structure resulting from the conversion continued.
  12. FY2019AdvancedAnnual report

    「All of the euro-yen convertible bonds with stock acquisition rights due 2019 issued in December 2014 were subject to requests for exercise of the stock acquisition rights, and conversion into common shares has been completed.」

    Full conversion of the convertible bonds due 2019 was completed, and the capital structure changed due to factors including a decrease in treasury shares associated with the conversion. The bonds due 2021 remained outstanding at ¥25.2 billion.
  13. FY2019-Q3AdvancedAnnual report

    「During the nine-month consolidated period ended 31 December, convertible bonds with stock acquisition rights were converted. The carrying amounts of the converted bonds were ¥41,663 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2019 and ¥23,217 million for TERUMO CORPORATION's euro-yen convertible bonds with stock acquisition rights due 2021.」

    The conversion of convertible bonds with stock acquisition rights continued, with bonds totaling ¥64,880 million converted. The conversion reduced bonds and borrowings by ¥60.5 billion and increased total equity by ¥121.9 billion.
  14. FY2019-Q2First statedAnnual report

    「Total equity increased by ¥127.6 billion to ¥678.1 billion. This was mainly due to a ¥64.6 billion increase resulting from the conversion of convertible bonds with stock acquisition rights, including a decrease in treasury shares used for the conversion, and a ¥37.5 billion increase in the foreign currency translation adjustment for foreign operations resulting from exchange-rate movements and other factors.」

    During the six-month consolidated period ended 30 September, convertible bonds with stock acquisition rights were converted, increasing equity attributable to owners of the parent from ¥550,307 million to ¥677,936 million.
Moved together

"Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets" moved the same way as this thread, in the same document, in 12 of its 14 moves.

121211101010★123456
  1. ★This thread
  2. 1Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets12×
  3. 2Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network12×
  4. 3Integration and Strengthening of the Global Production System, Including the Vietnam Factory11×
  5. 4High-value-added products for healthcare settings and revenue management10×
  6. 5Consistent Dividend Growth and a Medium- to Long-Term Payout Ratio of 30%10×
  7. 6Reinvestment of Retained Earnings in Research and Development, Production Facilities and Overseas Expansion10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Change in Capital Structure Due to Conversion of Convertible Bonds with Stock Acquisition Rights | TERUMO CORPORATION (4543) | Komori